Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Protagenic Therapeutics, Inc. - Common Stock
(NQ:
PTIX
)
2.150
-0.100 (-4.44%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Protagenic Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
September 16, 2024
Via
Benzinga
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via
Benzinga
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q2 2024
August 15, 2024
Protagenic Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
April 17, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
April 01, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
March 27, 2024
Via
ACCESSWIRE
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q1 2024
June 25, 2024
Protagenic Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 23, 2024
Via
Benzinga
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
May 22, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
May 01, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
March 25, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
February 13, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
September 26, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 23, 2024
Via
Benzinga
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023
April 01, 2024
Protagenic Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
March 21, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 05, 2024
Via
Benzinga
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split
March 22, 2023
Via
ACCESSWIRE
Earnings Scheduled For April 1, 2024
April 01, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 04, 2023
Via
Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 01, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 21, 2022
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
On Thursday, 116 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today